|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.46 USD | -0.59% |
|
+0.85% | -2.49% |
| 05-13 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 05-06 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
| Market Cap | 2.81B 2.46B 2.27B 2.1B 3.98B 268B 4.04B 27.11B 10.65B 132B 10.56B 10.33B 454B | P/E 2026 * |
109x | P/E 2027 * | 32.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.81B 2.46B 2.27B 2.1B 3.98B 268B 4.04B 27.11B 10.65B 132B 10.56B 10.33B 454B | EV / Sales 2026 * |
3.24x | EV / Sales 2027 * | 2.75x |
| Free-Float |
95.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supernus Pharmaceuticals, Inc.
| 1 day | -0.59% | ||
| 1 week | +0.85% | ||
| Current month | +4.19% | ||
| 1 month | +9.12% | ||
| 3 months | -4.38% | ||
| 6 months | -5.65% | ||
| Current year | -2.49% |
| 1 week | 47.04 | 51.37 | |
| 1 month | 42.45 | 51.37 | |
| Current year | 42.45 | 59.68 | |
| 1 year | 32.2 | 59.68 | |
| 3 years | 21.99 | 59.68 | |
| 5 years | 21.99 | 59.68 | |
| 10 years | 13.12 | 61.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
CEO | Chief Executive Officer | 64 | 22/12/2005 |
Timothy Dec
DFI | Director of Finance/CFO | 67 | 23/08/2021 |
| Compliance Officer | 63 | 01/01/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Khattar
BRD | Director/Board Member | 64 | 22/12/2005 |
Charles Newhall
CHM | Chairman | 81 | 10/08/2016 |
Frederick Hudson
BRD | Director/Board Member | 80 | 16/11/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-16 | Fiscal year | Chief Technology Officer | 321,750 | 0.5738% | ||
| 03-13 | Others | Founder | 60,000 | 0.1070% | ||
| 03-12 | Sell | Director | 5,369 | 0.0096% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.59% | +0.85% | +46.32% | +58.89% | 2.81B | ||
| -1.22% | -4.65% | +48.20% | +14.95% | 305B | ||
| +0.07% | -4.09% | +23.85% | -6.68% | 69.44B | ||
| -3.08% | -4.09% | +33.33% | +104.89% | 9.04B | ||
| -0.40% | -3.84% | +6.28% | +1.15% | 8.56B | ||
| +2.74% | -4.41% | -16.17% | +11.80% | 4.3B | ||
| +1.60% | -9.66% | +14.10% | +29.75% | 4.09B | ||
| +1.63% | -2.70% | -38.68% | +21.29% | 3.4B | ||
| +2.24% | -2.33% | +10.24% | -21.40% | 2.14B | ||
| +2.44% | -3.48% | -17.93% | +27.01% | 1.81B | ||
| Average | +0.54% | -2.81% | +10.95% | +24.17% | 41.07B | |
| Weighted average by Cap. | -0.89% | -4.36% | +40.65% | +13.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 867M 759M 700M 646M 1.23B 82.71B 1.25B 8.36B 3.28B 40.74B 3.26B 3.19B 140B | 1.02B 895M 825M 762M 1.45B 97.56B 1.47B 9.86B 3.87B 48.06B 3.84B 3.76B 165B |
| Net income | 25.92M 22.68M 20.92M 19.32M 36.65M 2.47B 37.27M 250M 98.14M 1.22B 97.34M 95.22M 4.19B | 92.99M 81.34M 75.03M 69.3M 131M 8.87B 134M 896M 352M 4.37B 349M 342M 15.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $48.46 | -0.59% | 1,126,231 |
| 09/07/26 | $48.75 | -3.35% | 1,296,246 |
| 08/07/26 | $50.44 | +5.21% | 1,430,876 |
| 07/07/26 | $47.94 | +1.48% | 1,017,845 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPN Stock
Select your edition
All financial news and data tailored to specific country editions

















